IC
GILD icon

Inscription Capital’s Gilead Sciences GILD Stock Holding History

Inscription Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$494K Sell
3,910
-895
-19% -$118K 0.04% 397
2026
Q1 		$670K Sell
4,805
-147
-3% -$20.6K 0.07% 282
2025
Q4 		$608K Buy
4,952
+296
+6% +$36K 0.06% 306
2025
Q3 		$517K Buy
4,656
+1,224
+36% +$139K 0.06% 346
2025
Q2 		$381K Buy
+3,432
New +$365K 0.05% 291
2022
Q3 		– Sell
-4,397
Closed -$272K – 219
2022
Q2 		$272K Buy
+4,397
New +$272K 0.05% 213
2021
Q3 		– Sell
-3,687
Closed -$254K – 280
2021
Q2 		$254K Buy
+3,687
New +$246K 0.03% 279

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Inscription Capital's GILD Position: Q2 2026 in Review

Inscription Capital reduced its Gilead Sciences (GILD) stake by 19% in Q2 2026, selling an estimated $118K and leaving 3,910 shares worth $494K. The position accounts for 0.04% of the portfolio, ranked #397.

Inscription Capital first reported a position in GILD in Q2 2021 and has held it in 7 quarters since. The position peaked at $670K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Inscription Capital held 3,910 shares of Gilead Sciences worth $494K as of Q2 2026.
  • Inscription Capital sold 895 Gilead Sciences shares in Q2 2026, an estimated $118K.
  • Gilead Sciences made up 0.04% of Inscription Capital's portfolio in Q2 2026, its #397 holding.
  • Inscription Capital first reported a position in Gilead Sciences in Q2 2021 and has held it in 7 quarters since.
  • Inscription Capital's Gilead Sciences position peaked at $670K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Inscription Capital's 13F filing for Q2 2026, filed 13 Aug 2026.